Capex / expansionFiled on BSE ·
Jubilant Pharmova invests CAD 94.5 million to double RUBY-FILL® capacity
Jubilant Pharmova Ltd · Pharmaceuticals & Biotechnology
What the filing says
- Investment announced on October 8, 2026, to expand Kirkland, Québec facility
- Government of Canada provides CAD 23.8 million financial support through Strategic Response Fund
- Expansion aims to double production capacity of RUBY-FILL®, a cardiac PET imaging radiopharmaceutical
Original filing
Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Waaree Energies
Electrical Equipment
Revenue growth 40%+Margin up 2%+
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other capex / expansion filings this fortnight
- Capex / expansionFredun PharmaFredun Pharmaceuticals transitions to branded healthcare and expands pet care
- Capex / expansionKabra Extrusion Technik LtdKabra Extrusiontechnik commissions 10 MW/20 MWh Battery Energy Storage System
- Capex / expansionBrigade Enterpr.Brigade Group announces ₹40,000 crore investment for 3-year growth plan
- Capex / expansionPower Grid CorpnPower Grid Corporation commissions 2500 MW Solar Transmission Project in Karnataka
- Capex / expansionPolyplex Corporation LtdPolyplex to add 12,000 MT capacity with second-hand film line in Thailand
- Capex / expansionVoltamp Transformers LtdVoltamp Transformers Limited begins commercial production at new plant Unit-III
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.